✦ LIBER ✦

Nuclear receptors as therapeutic targets in cholestatic liver diseases

✍ Scribed by Gernot Zollner; Michael Trauner

Book ID: 111218073
Publisher: Nature Publishing Group
Year: 2009
Tongue: English
Weight: 373 KB
Volume: 156
Category: Article
ISSN: 0007-1188
DOI: 10.1111/j.1476-5381.2008.00030.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The nuclear bile acid receptor FXR as a

The nuclear bile acid receptor FXR as a novel therapeutic target in cholestatic liver diseases: Hype or hope?

✍ Michael Trauner 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 216 KB 👁 2 views

Farnesoid X receptor (FXR) is a bile acid-activated transcription factor that is a member of the nuclear hormone receptor superfamily. FXR-null mice exhibit a phenotype similar to Byler disease, an inherited cholestatic liver disorder. In the liver, activation of FXR induces transcription of transpo

CB2 receptors as new therapeutic targets

CB2 receptors as new therapeutic targets for liver diseases

✍ S Lotersztajn; F Teixeira-Clerc; B Julien; V Deveaux; Y Ichigotani; S Manin; J T 📂 Article 📅 2008 🏛 Nature Publishing Group 🌐 English ⚖ 117 KB

Nuclear Receptors, Inflammation, and Liv

Nuclear Receptors, Inflammation, and Liver Disease: Insights for Cholestatic and Fatty Liver Diseases

✍ Arrese, M; Karpen, S J 📂 Article 📅 2010 🏛 Nature Publishing Group 🌐 English ⚖ 115 KB

Toll-like receptors as potential therape

Toll-like receptors as potential therapeutic targets for multiple diseases

✍ Zuany-Amorim, Claudia; Hastewell, John; Walker, Christoph 📂 Article 📅 2002 🏛 Nature Publishing Group 🌐 English ⚖ 904 KB

Alpha7 nicotinic receptors as novel ther

Alpha7 nicotinic receptors as novel therapeutic targets for inflammation-based diseases

✍ Merouane Bencherif; Patrick M. Lippiello; Rudolf Lucas; Mario B. Marrero 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 491 KB

Nuclear receptors in liver disease

✍ Martin Wagner; Gernot Zollner; Michael Trauner 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 335 KB

Nuclear receptors are ligand-activated transcriptional regulators of several key aspects of hepatic physiology and pathophysiology. As such, nuclear receptors control a large variety of metabolic processes including hepatic lipid metabolism, drug disposition, bile acid homeostasis, as well as liver